FDA Approves New Therapy for Myelodysplastic Syndromes (MDS) That Can Be Taken at Home
WASHINGTON, D.C. — The U.S. Food and Drug Administration this week approved Inqovi (decitabine and cedazuridine) tablets for treatment of adult patients with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia …
Read More